#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stargardt's disease PIK3CA-activated mutation Arteriosclerosis Hepato-lenticular degeneration Squamous cell carcinoma of the oral cavity MELAS syndrome Crohn's disease Colitis ulcerative Juvenile psoriatic arthritis Ventricular tachycardia Astrocytoma malignant Trigeminal neuralgia Extranodal marginal zone B-cell lymphoma (MALT type) Follicular lymphoma Palmoplantar pustulosis More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Life with Disease Focal segmental glomerulosclerosis – Basic Information Mucopolysaccharidosis – Life with Disease Haemophilia A without inhibitors – Trials in Disease Aicardi-Goutieres syndrome – Basic Information SAPHO syndrome – Life with Disease Alternating hemiplegia of childhood – Trials in Disease Mantle cell lymphoma stage IV – Trials in Disease Pleomorphic leiomyosarcoma – Life with Disease Methylmalonic acidaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ide397 ALPROSTADIL Brexpiprazole Paroxetine Bp1.7881A Axitinib Disodium Folinate Cx-037231 Lidocaine BGB-16673 Lenacapavir Ttf-Ngr Leniolisib Phosphate Zasocitinib Fremanezumab A/(H3N2)-LIKE VIRUS ANTIGEN Dazucorilant Padeliporfin Aup1602-C Lu Ag09222 More therapies…

    Learn about Your Condition

    Congenital pseudarthrosis Toxic nodular goitre Alcohol abuse Petit mal epilepsy Pleural mesothelioma Gallbladder cancer Trisomy 21 Obsessive-compulsive disorder Rheumatoid arthritis Acute leukaemia Laryngeal cancer stage III Lung adenocarcinoma Pre-eclampsia Vasospasm Tourette's disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Huntington’s disease

  • Study on the Safety and Effects of AMT-130 for Adults with Early Huntington’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • Ifezuntirgene Inilparvovec
    Poland

  • Safety and Tolerability Study of AB-1001 Brain Injection in Adults with Early Huntington’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype Rh10 Containing The Human Cholesterol 24-Hydroxylase Gene
    • Methylprednisolone Hemisuccinate
    • Fludeoxyglucose (18F)
    France

  • Study on the Safety and Effects of PTC518 for Patients with Huntington’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • Ptc518
    Austria France Germany Italy The Netherlands Spain

  • Study on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • Tominersen
    Austria Denmark France Germany Italy Poland +2

  • Study on Long-Term Safety and Effects of PTC518 for Patients with Huntington’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • VOTOPLAM
    Austria France Germany Italy The Netherlands Spain

  • Study on the Safety and Effects of MBF-015 for Patients with Huntington’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • Mbf-015
    Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!